Biophytis S.A. BPTSY
Set alert
At close · Feb 5
- YTD
- +4,445.45%
- 1 year
- -82.01%
- Open
- 1.38
- Prev close
- 0.50
- Mkt cap
- 18.69M
- Vol
- 20
- Avg vol
- 0
- EPS
- -3.70
- P/E
- 0.00
More statistics
- Low
- 1.38
- High
- 1.38
News
1 year ago newsfilecorp.com
Biophytis Targets Mobility Restoration in Patients with Obesity
Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - April 22, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in…
1 year ago newsfilecorp.com
Biophytis Confirms the Launch of the Phase 2 OBA Clinical Trial in Obesity
Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - April 9, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
1 year ago newsfilecorp.com
Biophytis Announces New Non-Clinical Data Further Supporting Its Mission to Pioneer the Restoration of Mobility in Patients with Obesity
96% of patients with obesity report experiencing muscle strength impairment, affecting their mobility New preclinical study results: The combination of BIO101 and GLP-1 induced muscle strength and…
1 year ago newsfilecorp.com
Biophytis Revolutionizes Sarcopenia
Publication of SARA-INT Phase II results for BIO101 Confirmation of Phase 3 readiness Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - March 17, 2025) - Biophytis SA (FP: ALBPS)…
1 year ago newsfilecorp.com
Biophytis Announces its Participation in the 15th International Conference on Frailty and Sarcopenia Research (ICFSR)
Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - February 25, 2025) - Biophytis SA (FP: ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
1 year ago newsfilecorp.com
Biophytis Unveils Its Outlook Strategies for 2025
Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - February 11, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
1 year ago newsfilecorp.com
Biophytis Announces Its Participation to the BIOMED FORUM Investor Conference
Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 27, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…
1 year ago newsfilecorp.com
Biophytis and AskHelpU Sign a Co-Development Agreement in Rare Neuromuscular Diseases in China
Paris, France and Cambridge, Massachusetts--(Newsfile Corp. - January 21, 2025) - Biophytis SA (FP: ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specializing in the…